{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:22:24Z","timestamp":1773696144085,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP18dm0107119"],"award-info":[{"award-number":["JP18dm0107119"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.pbb.2018.11.010","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T09:35:41Z","timestamp":1543397741000},"page":"57-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine"],"prefix":"10.1016","volume":"176","author":[{"given":"Zhongwei","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamaki","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoyu","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jincao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2018.11.010_bb0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pharmthera.2018.05.010","article-title":"The neurobiology of depression, ketamine and rapid-acting antidepressants: is it glutamate inhibition or activation?","volume":"190","author":"Abdallah","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2018.11.010_bb0010","first-page":"509","article-title":"The effects of quinacrine, proglumide, and pentoxifylline on seizure activity, cognitive deficit, and oxidative stress in rat lithium-pilocarpine model of status epilepticus","volume":"630","author":"Ahmad","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.pbb.2018.11.010_bb0015","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1120972","article-title":"Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress","volume":"311","author":"Berton","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pbb.2018.11.010_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1582-4934.2006.tb00289.x","article-title":"Inwardly rectifying potassium channels (Kir) in central nervous system glia: a special role for Kir4.1 in glial functions","volume":"10","author":"Butt","year":"2006","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.pbb.2018.11.010_bb0025","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/1570159X15666170221101054","article-title":"Beyond ketamine: new approaches to the development of safer antidepressants","volume":"15","author":"Chaki","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pbb.2018.11.010_bb0030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature25752","article-title":"Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression","volume":"554","author":"Cui","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2018.11.010_bb0035","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/ALN.0b013e3181ed09a2","article-title":"Taming the ketamine tiger. 1965","volume":"113","author":"Domino","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pbb.2018.11.010_bb0040","first-page":"228","article-title":"Rapid and sustained antidepressant action of the mGlu2\/3 receptor antagonist MGS0039 in the social defeat stress model: comparison with ketamine","volume":"20","author":"Dong","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2018.11.010_bb0045","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14344.1","article-title":"Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide","volume":"7","author":"Duman","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.pbb.2018.11.010_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.116.239228","article-title":"Antidepressant potential of (R)-ketamine in rodent models: comparison with (S)-ketamine","volume":"361","author":"Fukumoto","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2018.11.010_bb0055","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/nprot.2011.361","article-title":"A standardized protocol for repeated social defeat stress in mice","volume":"6","author":"Golden","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.pbb.2018.11.010_bb0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.9758\/cpn.2014.12.1.72","article-title":"The R-stereoisomer of ketamine as an alternative for ketamine for treatment-resistant major depression","volume":"12","author":"Hashimoto","year":"2014","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.pbb.2018.11.010_bb0065","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1017\/S0033291716000969","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity","volume":"46","author":"Hashimoto","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pbb.2018.11.010_bb0070","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/14728222.2016.1238899","article-title":"Ketamine's antidepressant action: beyond NMDA receptor inhibition","volume":"20","author":"Hashimoto","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.pbb.2018.11.010_bb0075","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1176\/appi.ajp.2016.16040411","article-title":"Detrimental side effects of repeated ketamine infusions in the brain","volume":"173","author":"Hashimoto","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2018.11.010_bb0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00406-016-0692-7","article-title":"Reduction of dopamine D2\/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys","volume":"267","author":"Hashimoto","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pbb.2018.11.010_bb0085","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/sj.bjp.0706108","article-title":"Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors","volume":"144","author":"Hirano","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2018.11.010_bb0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/1874241600902010007","article-title":"Improvement of phencyclidine-induced cognitive deficits in mice by subsequent subchronic administration of fluvoxamine, but not sertraline","volume":"2","author":"Ishima","year":"2009","journal-title":"Open Clin. Chem. J."},{"key":"10.1016\/j.pbb.2018.11.010_bb0095","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fnmol.2017.00408","article-title":"Inhibition of inwardly rectifying potassium (Kir) 4.1 channels facilitates brain-derived neurotrophic factor (BDNF) expression in astrocytes","volume":"10","author":"Kinboshi","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pbb.2018.11.010_bb0100","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pbb.2018.11.010_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/srep39209","article-title":"Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: role of BDNF-TrkB signaling","volume":"6","author":"Ma","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbb.2018.11.010_bb0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.brainres.2017.03.009","article-title":"Inhibition of Kir4.1 potassium channels by quinacrine","volume":"1663","author":"Marmolejo-Murillo","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2018.11.010_bb0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.conb.2014.12.004","article-title":"Antidepressant actions of ketamine: from molecular mechanisms to clinical practice","volume":"30","author":"Monteggia","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pbb.2018.11.010_bb0120","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"APA Council of Research Task Force on Novel Biomarkers and Treatments. Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2018.11.010_bb0125","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4103\/1673-5374.230355","article-title":"Astrocytic Kir4.1 potassium channels as a novel therapeutic target for epilepsy and mood disorders","volume":"13","author":"Ohno","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.pbb.2018.11.010_bb0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2007.08.018","article-title":"Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors","volume":"1178","author":"Ohno","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2018.11.010_bb0135","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.euroneuro.2015.09.002","article-title":"Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist","volume":"25","author":"Shirayama","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2018.11.010_bb0140","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S2215-0366(17)30102-5","article-title":"Ketamine treatment for depression: opportunities for clinical innovation and ethica foresight","volume":"4","author":"Singh","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pbb.2018.11.010_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pbb.2018.07.003","article-title":"Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of (R,S)-ketamine and (S)-ketamine, but not (R)-ketamine","volume":"172","author":"Tian","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2018.11.010_bb0150","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nn1659","article-title":"Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action","volume":"9","author":"Tsankova","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pbb.2018.11.010_bb0155","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1176\/appi.ajp.2017.17020239","article-title":"A survey of the clinical, off-label use of ketamine as a treatment for psychiatric disorders","volume":"174","author":"Wilkinson","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2018.11.010_bb0160","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2018.11.010_bb0165","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv124","article-title":"Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis","volume":"19","author":"Xu","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2018.11.010_bb0170","doi-asserted-by":"crossref","first-page":"pyu121","DOI":"10.1093\/ijnp\/pyu121","article-title":"Regional differences in brain-derived neurotrophic factor levels and dendritic spine density confer resilience to inescapable stress","volume":"18","author":"Yang","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2018.11.010_bb0175","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pbb.2018.11.010_bb0180","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00406-016-0693-6","article-title":"Regional differences in the expression of brain-derived neurotrophic factor (BDNF) pro-peptide, proBDNF and preproBDNF in the brain confer stress resilience","volume":"266","author":"Yang","year":"2016","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pbb.2018.11.010_bb0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.psychres.2016.03.034","article-title":"Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine","volume":"239","author":"Yang","year":"2016","journal-title":"Psychiatric. Res."},{"key":"10.1016\/j.pbb.2018.11.010_bb0190","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.biopsych.2016.12.020","article-title":"(R)-ketamine shows greater potency and longer lasting antidepressant effects than its metabolite (2R,6R)-hydroxynorketamine","volume":"82","author":"Yang","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2018.11.010_bb0195","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/s41398-017-0031-4","article-title":"Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"7","author":"Yang","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pbb.2018.11.010_bb0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","article-title":"Mechanistic target of rapamycin-independent antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"83","author":"Yang","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2018.11.010_bb0205","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2018.11.010_bb0210","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pbb.2018.11.010_bb0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R(-)-ketamine shows greater potency and longer lasting antidepressant effects than S(+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2018.11.010_bb0220","article-title":"Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation","volume":"18","author":"Zhang","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2018.11.010_bb0225","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1007\/s00213-015-4062-3","article-title":"Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression","volume":"232","author":"Zhang","year":"2015","journal-title":"Psychopharmacology"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718305914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718305914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T04:32:09Z","timestamp":1605501129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305718305914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":45,"alternative-id":["S0091305718305914"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2018.11.010","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2018.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}